Olympus Corporation (TYO:7733)
1,900.00
-14.50 (-0.76%)
Jun 13, 2025, 3:30 PM JST
Olympus Revenue
In the fiscal year ending March 31, 2025, Olympus had annual revenue of 997.33B JPY with 6.53% growth. Olympus had revenue of 272.11B in the quarter ending March 31, 2025, with 4.46% growth.
Revenue
997.33B
Revenue Growth
+6.53%
P/S Ratio
2.15
Revenue / Employee
34.58M
Employees
28,838
Market Cap
2,142.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 997.33B | 61.12B | 6.53% |
Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
Mar 31, 2021 | 730.54B | -66.87B | -8.39% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.30B |
Olympus News
- 4 weeks ago - Olympus Corporation (OLYMY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Olympus Corporation 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 4 months ago - Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Olympus Launches Global Search for New CEO Amid Leadership Transition - CEOWORLD magazine
- 7 months ago - Olympus Corporation (OLYMY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Olympus shares drop over 5% after CEO resigns over drug allegation - CNBC
- 8 months ago - Olympus CEO steps down amid illegal drug purchase allegations; endoscope manufacturer's shares drop 7% - Invezz
- 11 months ago - Olympus Corporation (OLYMY) Q1 2025 Earnings Call Transcript - Seeking Alpha